193 related articles for article (PubMed ID: 34556121)
1. Antibody signatures of asymptomatic Plasmodium falciparum malaria infections measured from dried blood spots.
Markwalter CF; Nyunt MH; Han ZY; Henao R; Jain A; Taghavian O; Felgner PL; Han KT; Nyunt MM; Plowe CV
Malar J; 2021 Sep; 20(1):378. PubMed ID: 34556121
[TBL] [Abstract][Full Text] [Related]
2. A novel method for extracting nucleic acids from dried blood spots for ultrasensitive detection of low-density Plasmodium falciparum and Plasmodium vivax infections.
Zainabadi K; Adams M; Han ZY; Lwin HW; Han KT; Ouattara A; Thura S; Plowe CV; Nyunt MM
Malar J; 2017 Sep; 16(1):377. PubMed ID: 28923054
[TBL] [Abstract][Full Text] [Related]
3. Multi-epitope chimeric antigen used as a serological marker to estimate Plasmodium falciparum transmission intensity in the border area of China-Myanmar.
Yao MX; Sun XD; Gao YH; Cheng ZB; Deng WW; Zhang JJ; Wang H
Infect Dis Poverty; 2016 Sep; 5(1):98. PubMed ID: 27604628
[TBL] [Abstract][Full Text] [Related]
4. Malaria epidemiology in central Myanmar: identification of a multi-species asymptomatic reservoir of infection.
Ghinai I; Cook J; Hla TT; Htet HM; Hall T; Lubis IN; Ghinai R; Hesketh T; Naung Y; Lwin MM; Latt TS; Heymann DL; Sutherland CJ; Drakeley C; Field N
Malar J; 2017 Jan; 16(1):16. PubMed ID: 28056979
[TBL] [Abstract][Full Text] [Related]
5. Validation of oral fluid samples to monitor serological changes to Plasmodium falciparum: an observational study in southern Zambia.
Chidi AP; Chishimba S; Kobayashi T; Hamapumbu H; Mharakurwa S; Thuma PE; Moss WJ
Malar J; 2011 Jun; 10():162. PubMed ID: 21663660
[TBL] [Abstract][Full Text] [Related]
6. Geographical heterogeneity in prevalence of subclinical malaria infections at sentinel endemic sites of Myanmar.
Liu Z; Soe TN; Zhao Y; Than A; Cho C; Aung PL; Li Y; Wang L; Yang H; Li X; Li D; Peng Z; Wang J; Li Y; Yang Z; Zhou H; Wang Q; Kyaw MP; Cao Y; Cui L
Parasit Vectors; 2019 Feb; 12(1):83. PubMed ID: 30777127
[TBL] [Abstract][Full Text] [Related]
7. Screening for malaria antigen and anti-malarial IgG antibody in forcibly-displaced Myanmar nationals: Cox's Bazar district, Bangladesh, 2018.
Lu A; Cote O; Dimitrova SD; Cooley G; Alamgir A; Uzzaman MS; Flora MS; Widiati Y; Akhtar MS; Vandenent M; Ehlman DC; Bennett SD; Feldstein LR; Rogier E
Malar J; 2020 Mar; 19(1):130. PubMed ID: 32228699
[TBL] [Abstract][Full Text] [Related]
8. Community-based molecular and serological surveillance of subclinical malaria in Myanmar.
O'Flaherty K; Oo WH; Zaloumis SG; Cutts JC; Aung KZ; Thein MM; Drew DR; Razook Z; Barry AE; Parischa N; Zaw NN; Thu HK; Thi A; Htay WYM; Soe AP; Simpson JA; Beeson JG; Agius PA; Fowkes FJI
BMC Med; 2021 May; 19(1):121. PubMed ID: 34044836
[TBL] [Abstract][Full Text] [Related]
9. Submicroscopic and asymptomatic Plasmodium falciparum and Plasmodium vivax infections are common in western Thailand - molecular and serological evidence.
Baum E; Sattabongkot J; Sirichaisinthop J; Kiattibutr K; Davies DH; Jain A; Lo E; Lee MC; Randall AZ; Molina DM; Liang X; Cui L; Felgner PL; Yan G
Malar J; 2015 Feb; 14():95. PubMed ID: 25849211
[TBL] [Abstract][Full Text] [Related]
10. Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia.
Wang Q; Zhao Z; Zhang X; Li X; Zhu M; Li P; Yang Z; Wang Y; Yan G; Shang H; Cao Y; Fan Q; Cui L
PLoS One; 2016; 11(3):e0151900. PubMed ID: 26999435
[TBL] [Abstract][Full Text] [Related]
11. Survey for asymptomatic malaria cases in low transmission settings of Iran under elimination programme.
Zoghi S; Mehrizi AA; Raeisi A; Haghdoost AA; Turki H; Safari R; Kahanali AA; Zakeri S
Malar J; 2012 Apr; 11():126. PubMed ID: 22533733
[TBL] [Abstract][Full Text] [Related]
12. Very high carriage of gametocytes in asymptomatic low-density Plasmodium falciparum and P. vivax infections in western Thailand.
Nguitragool W; Mueller I; Kumpitak C; Saeseu T; Bantuchai S; Yorsaeng R; Yimsamran S; Maneeboonyang W; Sa-Angchai P; Chaimungkun W; Rukmanee P; Puangsa-Art S; Thanyavanich N; Koepfli C; Felger I; Sattabongkot J; Singhasivanon P
Parasit Vectors; 2017 Oct; 10(1):512. PubMed ID: 29065910
[TBL] [Abstract][Full Text] [Related]
13. Pre-amplification methods for tracking low-grade Plasmodium falciparum populations during scaled-up interventions in Southern Zambia.
Mharakurwa S; Daniels R; Scott A; Wirth DF; Thuma P; Volkman SK
Malar J; 2014 Mar; 13():89. PubMed ID: 24618119
[TBL] [Abstract][Full Text] [Related]
14. Establishing the extent of malaria transmission and challenges facing pre-elimination in the Republic of Djibouti.
Noor AM; Mohamed MB; Mugyenyi CK; Osman MA; Guessod HH; Kabaria CW; Ahmed IA; Nyonda M; Cook J; Drakeley CJ; Mackinnon MJ; Snow RW
BMC Infect Dis; 2011 May; 11():121. PubMed ID: 21569328
[TBL] [Abstract][Full Text] [Related]
15. Malaria serology data from the Guiana shield: first insight in IgG antibody responses to Plasmodium falciparum, Plasmodium vivax and Plasmodium malariae antigens in Suriname.
Labadie-Bracho MY; van Genderen FT; Adhin MR
Malar J; 2020 Oct; 19(1):360. PubMed ID: 33032606
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Clinical and Subclinical
Huang F; Takala-Harrison S; Liu H; Xu JW; Yang HL; Adams M; Shrestha B; Mbambo G; Rybock D; Zhou SS; Xia ZG; Zhou XN; Plowe CV; Nyunt MM
Am J Trop Med Hyg; 2017 Nov; 97(5):1524-1531. PubMed ID: 29016341
[TBL] [Abstract][Full Text] [Related]
17. Specificity of the IgG antibody response to Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, and Plasmodium ovale MSP1
Priest JW; Plucinski MM; Huber CS; Rogier E; Mao B; Gregory CJ; Candrinho B; Colborn J; Barnwell JW
Malar J; 2018 Nov; 17(1):417. PubMed ID: 30413163
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for asymptomatic malaria infections from seasonal cross-sectional surveys along the China-Myanmar border.
Zhao Y; Zeng J; Zhao Y; Liu Q; He Y; Zhang J; Yang Z; Fan Q; Wang Q; Cui L; Cao Y
Malar J; 2018 Jul; 17(1):247. PubMed ID: 29973194
[TBL] [Abstract][Full Text] [Related]
19. Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum.
Estévez PT; Satoguina J; Nwakanma DC; West S; Conway DJ; Drakeley CJ
Malar J; 2011 Apr; 10():104. PubMed ID: 21527045
[TBL] [Abstract][Full Text] [Related]
20. Humoral immune response to Plasmodium falciparum vaccine candidate GMZ2 and its components in populations naturally exposed to seasonal malaria in Ethiopia.
Mamo H; Esen M; Ajua A; Theisen M; Mordmüller B; Petros B
Malar J; 2013 Feb; 12():51. PubMed ID: 23383869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
